November JAAD: Paradigm Shift in the Management of Infantile Hemangiomas in the Beta-blocker Era: A Retrospective Cohort Study

June 1, 2026

Infantile hemangiomas often require timely evaluation, and evolving treatment approaches have shifted how and when clinicians intervene. Hear from Esteban Fernandez Faith, MD and Robert Smith, MD as they discuss how the introduction of beta blockers has transformed management strategies for infantile hemangiomas.

Summary

Availability:

On-Demand

Expires on Jun 01, 2029

Credit Offered:

0.5 CME Credit

Recommended

Question of the Week Self-Assessment - 2026

13.25 CME

December JAAD: No Association Between Low-Dose Oral Minoxidil and Tachycardia in a Large Retrospective Cohort Study of Patients with Non-Scarring Alopecia

May 25, 2026

Low-dose oral minoxidil is increasingly used to treat non-scarring alopecia, but concerns about tachycardia can complicate patient counseling. Hear from Shari Lipner, MD, FAAD and Sanna Ronkainen, MD as they discuss how emerging safety data can help guide prescribing decisions for patients with hair loss.

0.5 CME

Hair Disorders Made Easier

April 20, 2026

Hair loss disorders are increasingly encountered in dermatologic practice and can be difficult to evaluate and treat. Join Maryanne Makredes Senna, MD, FAAD and Neal Bhatia, MD, FAAD as they discuss how practical diagnostic strategies can simplify the management of alopecia.

0.5 CME

Hidradenitis Suppurativa

March 30, 2026

A growing range of therapeutic options is influencing care for patients with hidradenitis suppurativa. Listen as Jennifer Hsiao, MD, FAAD and Jacquelyn Dosal, MD, FAAD examine how individualized, multimodal approaches can support more effective disease control.

0.5 CME

Melanoma in Special Populations

May 4, 2026

Melanoma risk and outcomes can vary significantly across different patient populations, often influenced by access to care and evolving risk factors. Hear from Jennifer G. Powers, MD, FAAD and Olayemi Sokumbi, MD, FAAD as they discuss how targeted screening strategies can improve early detection in high-risk groups.

0.5 CME

Opportunistic Infections and Drug Rashes Oh My: Managing the Cutaneous Complications of Solid Organ Transplantation

June 8, 2026

Solid organ transplant recipients face unique dermatologic challenges due to chronic immunosuppression and increased susceptibility to infection. Join Stephanie Gallitano, MD, FAAD and Lilia Correa-Selm, MD, FAAD as they discuss how thoughtful management can help navigate complex cutaneous complications in this population.

0.5 CME

Granulomatous Diseases: A Review and Update for 2026 and Beyond

June 15, 2026

Granulomatous diseases are often associated with complex diagnostic and therapeutic challenges, but emerging evidence is helping clinicians navigate these conditions with greater confidence. Listen as Jenna Koblinski, MD and Misha Rosenbach, MD, FAAD as they review current approaches to diagnosis, systemic evaluation, and treatment of granulomatous disorders.

0.5 CME

Evidence-Based Management of Melanocytic Neoplasms

March 23, 2026

Changing perspectives on melanocytic neoplasms are prompting reassessment of current long-standing practices. Listen as Jason Bok Lee, MD, FAAD and Hillary Johnson-Jahangir, MD, PhD, FAAD explore how risk stratification and emerging data can help refine management of pigmented lesions.

0.5 CME

Medical and Surgical Management of Nail Disorders

April 13, 2026

Nail disorders can present with subtle findings that make diagnosis and management particularly challenging. Hear from Molly A. Hinshaw, MD, FAAD and Hillary Johnson-Jahangir, MD, PhD, FAAD as they discuss how careful clinical evaluation can help identify and manage nail unit squamous cell carcinoma.

0.5 CME

Vitiligo

September 8, 2025

Recent developments in treatment for vitiligo are redefining what long-term management and re-pigmentation can look like. Listen as David Rosmarin, MD, FAAD and Olayemi Sokumbi, MD, FAAD discuss how these new therapies are reshaping long-term outcomes and expectations for patients and physicians alike.

0.5 CME